SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | Verrica Pharmaceuticals Inc. | 7,099,182 | 16.9% | EDGAR |
SC 13G | 2024-02-14 | Avoro Capital Advisors LLC | Verrica Pharmaceuticals Inc. | 6,583,332 | 10.0% | EDGAR |
SC 13G/A | 2023-02-14 | PERCEPTIVE ADVISORS LLC | Verrica Pharmaceuticals Inc. | 5,038,983 | 12.3% | EDGAR |
SC 13D | 2022-07-15 | Manning Paul B | Verrica Pharmaceuticals Inc. | 15,389,481 | 37.4% | EDGAR |
SC 13G/A | 2022-02-14 | PERCEPTIVE ADVISORS LLC | Verrica Pharmaceuticals Inc. | 3,610,412 | 13.1% | EDGAR |
SC 13G/A | 2022-02-14 | Manning Paul B | Verrica Pharmaceuticals Inc. | 10,627,577 | 38.6% | EDGAR |
SC 13G/A | 2022-02-11 | ORBIMED ADVISORS LLC | Verrica Pharmaceuticals Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2022-01-27 | Davidson Matt | Verrica Pharmaceuticals Inc. | 560,731 | 2.0% | EDGAR |
SC 13G/A | 2021-02-17 | PERCEPTIVE ADVISORS LLC | Verrica Pharmaceuticals Inc. | 3,410,412 | 13.2% | EDGAR |
SC 13G/A | 2021-02-16 | PERCEPTIVE ADVISORS LLC | Verrica Pharmaceuticals Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-02-16 | Manning Paul B | Verrica Pharmaceuticals Inc. | 9,837,747 | 38.0% | EDGAR |
SC 13G/A | 2021-01-25 | Davidson Matt | Verrica Pharmaceuticals Inc. | 1,445,003 | 5.6% | EDGAR |
SC 13G/A | 2020-02-14 | PERCEPTIVE ADVISORS LLC | Verrica Pharmaceuticals Inc. | 3,410,412 | 13.2% | EDGAR |
SC 13G/A | 2020-02-03 | Manning Paul B | Verrica Pharmaceuticals Inc. | 9,643,247 | 37.4% | EDGAR |
SC 13G/A | 2020-01-30 | Davidson Matt | Verrica Pharmaceuticals Inc. | 2,473,160 | 9.6% | EDGAR |
SC 13G | 2019-04-04 | Davidson Matt | Verrica Pharmaceuticals Inc. | 3,082,169 | 12.0% | EDGAR |
SC 13G/A | 2019-02-14 | PERCEPTIVE ADVISORS LLC | Verrica Pharmaceuticals Inc. | 3,410,412 | 13.3% | EDGAR |
SC 13G | 2019-02-06 | Manning Paul B | Verrica Pharmaceuticals Inc. | 9,574,861 | 37.3% | EDGAR |
SC 13G | 2018-08-02 | PERCEPTIVE ADVISORS LLC | Verrica Pharmaceuticals Inc. | 3,410,412 | 13.3% | EDGAR |
SC 13G | 2018-06-25 | OrbiMed Capital GP VI LLC | Verrica Pharmaceuticals Inc. | 1,479,733 | 5.8% | EDGAR |